Literature DB >> 10942391

SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization.

D J Carver1, M J Aman, K S Ravichandran.   

Abstract

Activation of the serine/threonine kinase Akt and the regulation of its activation are recognized as critical in controlling proliferative/survival signals via many hematopoietic receptors. In B lymphocytes, the B-cell receptor (BCR)-mediated activation of Akt is attenuated by co-cross-linking of BCR with the inhibitory receptor Fc gamma RIIB1, and the binding of the SH2 domain-containing inositol phosphatase, SHIP, to Fc gamma RIIB1. Because SHIP dephosphorylates phosphatidylinositol 3,4,5-trisphosphate (PIP3) and activation of Akt requires PIP3, the destruction of this phospholipid has been proposed as the mechanism for Akt inhibition. However, upstream kinases that activate Akt, such as PDK1, also require PIP3 for activation. In this report, we addressed whether SHIP inhibits Akt directly at the level of Akt recruitment to the membrane, indirectly through PDK recruitment/phosphorylation of Akt, or both. We generated stable B-cell lines expressing a regulatable, but constitutively membrane-bound Akt that still required PDK-dependent phosphorylation for activation. Several lines of evidence suggested that activation of this membrane-targeted Akt is not inhibited by Fc gamma RIIB1/SHIP and that PDK is not a target for SHIP-mediated inhibition. These data demonstrate that SHIP inhibits Akt primarily through regulation of Akt membrane localization. We also observed during these studies that Fc gamma RIIB1/SHIP does not inhibit p70(S6k) activation, even though several other PIP3-dependent events were down-regulated. Because the enhanced activation of Akt in the absence of SHIP correlates with hyperproliferation in the myeloid lineage, our data have implications for SHIP and Akt-dependent regulation of proliferation in the hematopoietic lineage. (Blood. 2000;96:1449-1456)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942391

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  The B-cell receptor signaling pathway as a therapeutic target in CLL.

Authors:  Jennifer A Woyach; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

Review 2.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

Review 3.  Hitting the golden TORget: curcumin's effects on mTOR signaling.

Authors:  Christopher S Beevers; Hongyu Zhou; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

Review 4.  Signaling mechanisms regulating B-lymphocyte activation and tolerance.

Authors:  Elias Hobeika; Peter J Nielsen; David Medgyesi
Journal:  J Mol Med (Berl)       Date:  2015-01-29       Impact factor: 4.599

5.  Anti-CD79 antibody induces B cell anergy that protects against autoimmunity.

Authors:  Ian R Hardy; Nadia Anceriz; François Rousseau; Matt B Seefeldt; Eric Hatterer; Magali Irla; Vanessa Buatois; Laurence E Chatel; Andrew Getahun; Ashley Fletcher; Laura Cons; Guillemette Pontini; Nicole A Hertzberg; Giovanni Magistrelli; Pauline Malinge; Mia J Smith; Walter Reith; Marie H Kosco-Vilbois; Walter G Ferlin; John C Cambier
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

6.  Design and use of an inducibly activated human immunodeficiency virus type 1 Nef to study immune modulation.

Authors:  S F Walk; M Alexander; B Maier; M L Hammarskjold; D M Rekosh; K S Ravichandran
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock.

Authors:  M Piccioni; C Monari; S Kenno; E Pericolini; E Gabrielli; D Pietrella; S Perito; F Bistoni; T R Kozel; A Vecchiarelli
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

Review 8.  Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes.

Authors:  Wai-Hang Leung; Tatyana Tarasenko; Silvia Bolland
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

9.  Osteopontin induces beta-catenin signaling through activation of Akt in prostate cancer cells.

Authors:  Brian W Robertson; Meenakshi A Chellaiah
Journal:  Exp Cell Res       Date:  2009-10-20       Impact factor: 3.905

10.  T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses.

Authors:  Tatyana Tarasenko; Hemanta K Kole; Anthony W Chi; Margaret M Mentink-Kane; Thomas A Wynn; Silvia Bolland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.